Characteristics of the clinical practice patterns of hemodialysis in Japan in consideration of DOPPS and the NKF/DOQI guidelines

Clinical and Experimental Nephrology

Volumn 12, Issue 3, 2008, Pages 165-170

  Kuriyama, Satoru ^a  

^a SAISEIKAI CENTRAL HOSPITAL   (Japan)

Author keywords

Anemia; DOPPS; Hypertension; K DOQI; Mortality

Indexed keywords

HEMOGLOBIN;

ARTERIOVENOUS FISTULA; BLOOD PRESSURE REGULATION; CLINICAL PRACTICE; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; JAPAN; MORTALITY; PRACTICE GUIDELINE; REVIEW;

GUIDELINES AS TOPIC; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; QUALITY ASSURANCE, HEALTH CARE; RENAL DIALYSIS;

EID: 44149100301     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-007-0020-7     Document Type: Review

References (57)

1. Ghavamian M, Gutch CF, Kopp KF, Kolff WJ. The sad truth about hemodialysis in diabetic nephropathy. JAMA. 1972;222:1386-9.
2. Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, Greenwood R, Feldman HI, Port FK, Held PJ. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2004;19:121-32.
3. Young EW, Satayathum S, McCullough K, Bommer J, Andreucci V, Goodkin DA, Mapes DL, Dykstra DM, Port FK, Held PJ. European facility practice patterns related to mineral metabolism in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2002;17:23-30.
4. Saran R, Pisoni RL, Weitzel WF. Epidemiology of vascular access for hemodialysis and related practice patterns. Contrib Nephrol. 2004;142:14-28.
5. Rayner HC, Pisoni RL, Gillespie BM, Goodkin DA, Akiba T, Akizawa T, Saito A, Young EW, Port FK. Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2003;63:323-30.
6. Young EW, Dykstra DM, Goodkin DA, Mapes DL, Wolfe RA, Held PJ. Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2002;61:2266-71.
7. Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, Locatelli F, Bommer J, Cruz JM, Kerr PG, Mendelssohn DC, Held JP, Port FK. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44(7):94-111.
8. Pisoni RL, Young EW, Combe C, Leavey SF, Geenwood RN, Hecking E, Canaud BJ, Locatelli F. Higher catheter use within facilities is associated with increased mortality and hospitalization: result from DOPPS. J Am Soc Nephrol. 2001;12:299 A.
9. Akizawa T, Young EW, Maroni BJ, Andreucci VE, Kurokawa K, Marumo F, Held PJ. Nutritional status across three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2000;11:254A.
10. Mapes DL, Lopes AA, Satayathum S, McCullough KP, Goodkin DA, Locatelli F, Fukuhara S, Young EW, Kurokawa K, Saito A, Bommer J, Wolfe RA, Held PJ, Port FK. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2003;64:339-49.
11. Fukuhara S, Lopes AA, Bragg-Gresham JL, Kurokawa K, Mapes DL, Akizawa T, Bommer J, Canaud BJ, Port FK, Held PJ. Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2003;64:1903-10.
12. Pifer TB, Satayathum S, Dykstra DM, Mapes DL, Goodkin DA, Canaud B, Bommer J, Kurokawa K, Held PJ, Pisoni RL, Wolfe RA, Young EW. Hemodialysis staffing and patient outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2002;13:425A.
13. Saran R, Bragg-Gresham JL, Rayner HC, Goodkin DA, Keen ML, Van Dijk PC, Kurokawa K, Piera L, Saito A, Fukuhara S, Young EW, Held PJ, Port FK. Non-adherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int. 2003;64:254-62.
14. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Aizawa T, Kirokawa K, Bommer J, Piera L, Port FK. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2005;67(3):1179-87.
15. Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, Saito A, La-Brecque J, Port FK, Young EW. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2003;63:2222-9.
16. Fissel RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young EW. Pattern of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004;65(6):2335-42.
17. Saran R, Dykstra DM, Wolfe RA, Gillespie B, Held PJ, Young EW. Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2002;40:1255-63.
18. Vassalottie JA, Falk A, Cohl ED, Uribarri J, Teodorescue V. Obese and non-obese hemodialysis patients have a similar prevalence of functioning arteriovenous fistula using pre-operative vein mapping. Clin Nephrol. 2002;58:211-4.
19. Lopes AA, Bragg J, Young E, Goodkin D, Mapes D, Combe C, Piera L, Held P, Gillespie B, Port FK. Dialysis Outcomes and Practice Patterns Study (DOPPS). Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. 2002;62:199-207.
20. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizeman V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in DOPPS. Kidney Int. 2006;69:1222-8.
21. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003;14:3270-7.
22. Goodkin DA, Dickinson DM, Rasmussen CS, Kurokawa K, Akiba T, Held PJ. Components of hemodialysis dose: result from 7 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2000;11:320A.
23. Saran R, Canaud BJ, Depner TA, Keen ML, McCullough KP, Marshal MR, Port FK. Dose of dialysis: key lessons from major observational studies and clinical trials. Am J Kidney Dis. 2004;11(44):s47-53.
24. Pifer TB, McCullough KP, Port FK, Goodkin DA, Maroni BJ, Held PJ, Young EW. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int. 2002;62:2238-45.
25. Leavey SF, McCullough KP, Hecking E, Goodkin DA, Port FK, Young EW. Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2001;16:2386-94.
26. Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK. Body size dose of hemodialysis, mortality. Results from USRDS Special Study. Am J Kidney Dis. 2000;35:80-8.
27. Port FK, Ashby VB, Dhingra RK, Roys E, Wolfe RA. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol. 2002;13:1061-6.
28. Port FK, Wolfe RA, Hulbert-Shearon TE, Daugiedas JT, Agodoa LYC, Jones C, Orzol SM, Held PJ. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the USRDS Dialysis Morbidity and Mortality Study. Am J Kidney Dis. 2001;37:276-86.
29. Port FK, Rasmussen CS, Leavy SF, Wolfe RA, Kurokawa K, Akizawa T, Saito A, Piera L, Held PJ, Young EW. Association of blood flow rate and treatment time with mortality risk in HD patients across three continents. J Am Soc Nephrol. 2001;12:343A-4A.
30. Port FK, Eknoyan G. The dialysis outcomes and practice patterns study (DOPPS) and the kidney disease outcomes quality initiatives (K/DOQI): a cooperative initiative to improve outcomes for hemodialysis patients worldwide. Am J Kidney Dis. 2004;44(5 suppl 2):s1-6.
31. NKF. DOQI clinical practice guidelines for hemodialysis adequacy. Am J Kidney Dis. 1997;30:S15-66.
32. National Kidney Foundation. DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis. 1997;30(suppl 3):S192-240.
33. National Kidney Foundation. K/DOQI clinical practice guidelines for anemia of chronic kidney disease: update 2000. Am J Kidney Dis. 2001;37(suppl 1):S182-238.
34. National Kidney Foundation. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2005;45(4 suppl 3):S1-138.
35. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1-266.
36. National Kidney Foundation. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis. 2003;41(suppl 3):S1-91.
37. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(suppl 3):S1-201.
38. National Kidney Foundation. K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2000;35(suppl 1):S1-140.
39. National Kidney Foundation. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(suppl 3):S1-153.
40. Locatelli F, Pisoni RL, Akizawa T, Cruz JM, DeOreo PB, Lameire NH, Held PJ. Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings. Am J Kidney Dis. 2004;44(5 Suppl 2):27-33.
41. Port FK, Eknoyan G. The Dialysis Outcomes and Practice Patterns Study (DOPPS) and the Kidney Disease Outcomes Quality Initiative (K/DOQI): a cooperative initiative to improve outcomes for hemodialysis patients worldwide. Am J Kidney Dis. 2004;44(5 Suppl 2):1-6.
42. Combe C, McCullough KP, Asano Y, Ginsberg N, Maroni BJ,Pifer TB. Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices. Am J Kidney Dis. 2004;44(5 Suppl 2):39-46.
43. Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT. Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) Study Group. The Kidney Disease Outcomes Quality Initiative (K/DOQI) guideline for bone metabolism, disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis. 2005;46(5):925-32.
44. NFK. DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis. 2006;47:S17-85.
45. Tsukamoto Y. Future perspectives of guidelines for dialysis patients worldwide (in Japanese). Rinsho-toseki. 2006;22(7):59-70.
46. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334(1):13-8.
47. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sower J for the National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Preservation of renal function in adults with hypertension and diabetes: a consensus approach. Am J Kidney Dis. 2000;36:646-61.
48. Hosoya T, Toshima R, Ichida K, Tabe A, Sakai O. Changes in renal function with aging among Japanese. Intern Med. 1995;34(6):520-7.
49. Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration. Effect of different blood pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trial. Lancet. 2003;362:1527-35.
50. Nakai S, Shinzato T, Sanaka T, Kikuchi K, Kitaoka T, Shinoda T, Yamazaki C, Sakai R, Omori H, Morita O, Iseki K, Kubo K, Tabei K, Masakane I, Fushimi K, Wada A, Miwa N, Akiba T. The current state of chronic dialysis treatment in Japan (as of December 31, 2000). J Jpn Soc Dial Ther. 2002;35:1155-1184.
51. Patient Registration Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan. An overview of regular dialysis treatment in Japan as of 31 December 2003. Ther Aphr Dial. 2005;9(6):431-58.
52. Iseki K, Nakai S, Shinzato T, Morita O, Sinoda T, Kikuchi K, Wada A, Kimata N, Akiba T. Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan. Ther Apher Dial. 2007;11(3):183-8.
53. Mazzuci N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient survival. Kidney Int. 2000;58(5):2147-54.
54. Yamamoto T, Shimizu M, Morioka M, Kitano M, Wakabayashi W, Aizawa N. Role of angiotensin II in the pathogenesis of hyperdipsia in chronic renal failure. JAMA. 1986;256(5):601-3.
55. Oldenburg B, MacDonald GJ, Shelley S. Controlled trial of enarapril in patients with chronic fluid overload undergoing dialysis. Brit Med J. 1988;296:1089-91.
56. Kuriyama S, Tomonari H, Sakai O. Effect of cilazapril on hyperdipsia in hemodialyzed patients. Blood Purif. 1996;14:35-41.
57. Kuriyama S, Otsuka Y, Iida R, Matsumoto K, Tokudome G, Hosoya T. Morning blood pressure predicts hypertensive organ damage in patients with renal diseases: effect of intensive antihypertensive therapy in patients with diabetic nephropathy. Intern Med. 2005;44(12):1239-46.